» Articles » PMID: 5772652

Adriamycin (NSC-123,127): a New Antibiotic with Antitumor Activity

Overview
Specialties Oncology
Pharmacology
Date 1969 Feb 1
PMID 5772652
Citations 72
Authors
Affiliations
Soon will be listed here.
Citing Articles

miR-218-5p and doxorubicin combination enhances anticancer activity in breast cancer cells through Parkin-dependent mitophagy inhibition.

Naso F, Bruqi K, Manzini V, Chiurchiu V, DOnofrio M, Arisi I Cell Death Discov. 2024; 10(1):149.

PMID: 38514650 PMC: 10957887. DOI: 10.1038/s41420-024-01914-7.


Revisiting treatment-related cardiotoxicity in patients with malignant lymphoma-a review and prospects for the future.

Rihackova E, rihacek M, Vyskocilova M, Valik D, Elbl L Front Cardiovasc Med. 2023; 10:1243531.

PMID: 37711551 PMC: 10499183. DOI: 10.3389/fcvm.2023.1243531.


Amyloid Disassembly: What Can We Learn from Chaperones?.

Almeida Z, Brito R Biomedicines. 2022; 10(12).

PMID: 36552032 PMC: 9776232. DOI: 10.3390/biomedicines10123276.


Evolution of Medical Approaches and Prominent Therapies in Breast Cancer.

Duan S, Buxton I Cancers (Basel). 2022; 14(10).

PMID: 35626053 PMC: 9140094. DOI: 10.3390/cancers14102450.


Genetic landscape of T cells identifies synthetic lethality for T-ALL.

OMeara C, Guerri L, Lawir D, Mateos F, Iconomou M, Iwanami N Commun Biol. 2021; 4(1):1201.

PMID: 34671088 PMC: 8528931. DOI: 10.1038/s42003-021-02694-x.